Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Creative Commons License

Hacohen Y., YiWong Y., Lechner C., Jurynczyk M., Wright S., KONUŞKAN B., ...More

JAMA NEUROLOGY, vol.75, no.4, pp.478-487, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.1001/jamaneurol.2017.4601
  • Journal Name: JAMA NEUROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.478-487
  • Hacettepe University Affiliated: Yes

Abstract

IMPORTANCE Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.